JP2009541373A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009541373A5 JP2009541373A5 JP2009516901A JP2009516901A JP2009541373A5 JP 2009541373 A5 JP2009541373 A5 JP 2009541373A5 JP 2009516901 A JP2009516901 A JP 2009516901A JP 2009516901 A JP2009516901 A JP 2009516901A JP 2009541373 A5 JP2009541373 A5 JP 2009541373A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- adjuvant
- peptide
- protein
- vaccine according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200600861 | 2006-06-28 | ||
| DKPA200600861 | 2006-06-28 | ||
| PCT/DK2007/000312 WO2008000261A2 (en) | 2006-06-28 | 2007-06-26 | Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009541373A JP2009541373A (ja) | 2009-11-26 |
| JP2009541373A5 true JP2009541373A5 (https=) | 2010-07-29 |
| JP5165681B2 JP5165681B2 (ja) | 2013-03-21 |
Family
ID=38845996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009516901A Expired - Fee Related JP5165681B2 (ja) | 2006-06-28 | 2007-06-26 | タンパク質断片又はペプチドカクテルとして送達される抗原を用いたワクチン接種によるサブドミナントエピトープを含むｔ細胞レパートリーの拡大 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8105614B2 (https=) |
| EP (3) | EP2402023A1 (https=) |
| JP (1) | JP5165681B2 (https=) |
| KR (1) | KR20090024292A (https=) |
| AU (1) | AU2007264205B2 (https=) |
| BR (1) | BRPI0713978A2 (https=) |
| CA (1) | CA2654271A1 (https=) |
| DK (1) | DK2040745T3 (https=) |
| ES (1) | ES2400531T3 (https=) |
| RU (1) | RU2490024C2 (https=) |
| WO (1) | WO2008000261A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID29858A (id) | 1998-11-04 | 2001-10-18 | Isis Innovation | Uji diagnostik tuberkulosis |
| AU2003242504A1 (en) * | 2002-07-13 | 2004-02-02 | Statens Serum Institut | Therapeutic tuberculosis vaccines |
| EP2160198A2 (en) * | 2007-05-31 | 2010-03-10 | Statens Serum Institut | Influenza vaccines |
| WO2009003474A1 (en) * | 2007-06-29 | 2009-01-08 | Statens Serum Institut | The use of monomycolyl glycerol (mmg) as an adjuvant |
| CA2700808C (en) | 2007-09-27 | 2017-11-14 | Immunovaccine Technologies Inc. | Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| ES2524699T3 (es) * | 2008-06-05 | 2014-12-11 | Immunovaccine Technologies Inc. | Composiciones que comprenden liposomas, un antígeno, un polinucleótido y un vehículo que comprende una fase continua de una sustancia hidrófoba |
| US20100015171A1 (en) * | 2008-07-15 | 2010-01-21 | Statens Serum Institute | Vaccines comprising tb 10.4 |
| WO2010060430A2 (en) * | 2008-11-28 | 2010-06-03 | Statens Serum Institut | Optimized influenza vaccines |
| ES2714383T3 (es) * | 2009-04-24 | 2019-05-28 | Statens Seruminstitut | Vacuna TB contra la tuberculosis para impedir la reactivación |
| EP2451478A4 (en) * | 2009-11-05 | 2013-11-20 | Us Navy | PLASMODIUM FALCIPARUM SPOROZOITE AND LIVERPHASE ANTIGENS THEREWITH |
| CA2780207A1 (en) * | 2009-11-18 | 2011-05-26 | Auburn University | Low antigen-dose immunization for maximizing t-helper cell 1 (th1) immunity against disease |
| US20120244178A1 (en) * | 2011-03-25 | 2012-09-27 | Denise Doolan | Plasmodium falciparum antigens |
| JP6758185B2 (ja) * | 2013-12-13 | 2020-09-23 | ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ | マルチエピトープｔａｒｐペプチドワクチンおよびその使用 |
| WO2015161853A1 (en) | 2014-04-24 | 2015-10-29 | Statens Serum Institut | New m.tuberculosis vaccines |
| CN117064854A (zh) * | 2023-08-14 | 2023-11-17 | 广州谦毅生物医药有限公司 | 一种卡瓦脂质体的制备技术 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4599230A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4599231A (en) | 1984-03-09 | 1986-07-08 | Scripps Clinic And Research Foundation | Synthetic hepatitis B virus vaccine including both T cell and B cell determinants |
| US4608251A (en) | 1984-11-09 | 1986-08-26 | Pitman-Moore, Inc. | LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues |
| US4601903A (en) | 1985-05-01 | 1986-07-22 | The United States Of America As Represented By The Department Of Health And Human Services | Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease |
| US4975282A (en) | 1985-06-26 | 1990-12-04 | The Liposome Company, Inc. | Multilamellar liposomes having improved trapping efficiencies |
| US6641814B1 (en) * | 1997-04-02 | 2003-11-04 | Statens Serum Institut | Nucleic acids fragments and polypeptide fragments derived from M. tuberculosis |
| EP0992580B1 (en) * | 1993-11-04 | 2005-03-09 | Innogenetics N.V. | Immunodominant human T-cell epitopes of Hepatitis C virus |
| WO1999051748A2 (en) * | 1998-04-07 | 1999-10-14 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| US6649170B1 (en) | 1999-05-12 | 2003-11-18 | Statens Serum Institut | Adjuvant combinations for immunization composition and vaccines |
| SE9903031D0 (sv) * | 1999-08-27 | 1999-08-27 | Eurodiagnostica Ab | Peptide mixture and vaccine against a chronic viral infection |
| WO2001024820A1 (en) * | 1999-10-07 | 2001-04-12 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
| AU2001281812B2 (en) | 2000-06-08 | 2005-04-07 | Valneva Austria Gmbh | Immunostimulatory oligodeoxynucleotides |
| AT410173B (de) | 2000-06-08 | 2003-02-25 | Cistem Biotechnologies Gmbh | Antigene zusammensetzung |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| GB0118532D0 (en) | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| AU2003245729A1 (en) * | 2002-06-27 | 2004-01-19 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating a cytotoxic t lymphocyte immune response |
| US7749520B2 (en) | 2004-07-07 | 2010-07-06 | Statens Serum Institut | Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids |
| CN1980638B (zh) | 2004-07-07 | 2011-10-12 | 国立血清研究所 | 用糖脂稳定基于脂质的佐剂制剂的组合物和方法 |
| FR2873467A1 (fr) | 2004-07-26 | 2006-01-27 | Proton World Internatinal Nv | Enregistrement d'une cle dans un circuit integre |
| ME00045B (me) * | 2006-01-26 | 2010-10-10 | Zoetis Services Llc | Nove kompozicije glikolipidnog adjuvansa |
| GB0608368D0 (en) * | 2006-04-28 | 2006-06-07 | Isis Innovation | Process for making Oligopeptides |
-
2007
- 2007-06-26 CA CA002654271A patent/CA2654271A1/en not_active Abandoned
- 2007-06-26 ES ES07764444T patent/ES2400531T3/es active Active
- 2007-06-26 BR BRPI0713978-0A patent/BRPI0713978A2/pt not_active IP Right Cessation
- 2007-06-26 AU AU2007264205A patent/AU2007264205B2/en not_active Expired - Fee Related
- 2007-06-26 EP EP11182884A patent/EP2402023A1/en not_active Withdrawn
- 2007-06-26 WO PCT/DK2007/000312 patent/WO2008000261A2/en not_active Ceased
- 2007-06-26 JP JP2009516901A patent/JP5165681B2/ja not_active Expired - Fee Related
- 2007-06-26 EP EP07764444A patent/EP2040745B1/en not_active Not-in-force
- 2007-06-26 DK DK07764444.1T patent/DK2040745T3/da active
- 2007-06-26 KR KR1020097001606A patent/KR20090024292A/ko not_active Ceased
- 2007-06-26 EP EP11182885A patent/EP2402024A1/en not_active Withdrawn
- 2007-06-26 RU RU2009102389/15A patent/RU2490024C2/ru not_active IP Right Cessation
- 2007-06-27 US US11/823,402 patent/US8105614B2/en not_active Expired - Fee Related
-
2011
- 2011-12-16 US US13/328,319 patent/US20120156282A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009541373A5 (https=) | ||
| Kaur et al. | TLR2 agonistic small molecules: detailed structure–activity relationship, applications, and future prospects | |
| US12070498B2 (en) | Conjugate vaccine targeting a disease-causing biological protein | |
| JP5654345B2 (ja) | 多量体マルチエピトープインフルエンザワクチン | |
| CN103747797B (zh) | 脂质体制剂 | |
| JP5775451B2 (ja) | インフルエンザを処置するための組成物および方法 | |
| EP2200638B1 (en) | Compositions for the transfection of cells | |
| RU2007145052A (ru) | Композиции пептидного конъюгата и способы для профилактики и лечения болезни альцгеймера | |
| JP2011512123A5 (https=) | ||
| RU2009102389A (ru) | Расширение спектра клеток для включения субдоминантных эпитопов путем вакцинации с антигенами, доставленными как белковые фрагменты или пептидные коктейли | |
| JP2011190278A (ja) | 粘膜体表面に接触させてワクチン抗原を包含する物質の効果を調節する新規非抗原性粘膜アジュバント処方 | |
| JP2003531128A (ja) | 修飾ペプチドを含む医薬調製物 | |
| JP6158097B2 (ja) | 炎症を抑制するためのペプチド | |
| JP5766894B2 (ja) | ワクチン増強剤としてのαチモシンペプチド | |
| CN102088992B (zh) | 肽基二酰基甘油酯 | |
| JP7050807B2 (ja) | 新規ペプチドベースのｐｃｓｋ９ワクチン | |
| JPWO2012147805A1 (ja) | 脳移行性機能性核酸及びその利用 | |
| CN119818665A (zh) | 新型发热伴血小板减少综合征病毒疫苗 | |
| JP2008531463A5 (https=) | ||
| KR20090009839A (ko) | 면역조절 올리고펩티드 | |
| CN101336110B (zh) | 预防或治疗肝损伤的肽及其衍生物及其应用 | |
| RU2003110420A (ru) | Дифференцирование gnrh-i и gnrh-ii | |
| JPWO2000051634A1 (ja) | 脂肪酸を構成成分とするワクチン製剤 | |
| CN102178926A (zh) | 预防或治疗肝损伤的肽 | |
| CN121693514A (zh) | 含有Braf肽两亲分子的组合物及其使用方法 |